Portfoliotracker

Freenome, Inc.

FRNM · NASDAQCM · Healthcare Diagnostics & Research 26/100 E

10,09 $
▼ −0,32 (−3,07 %)
Pre-market delayed by 15 min
Price as of 16. 11. 22:00, fetched 17. 11. 14:48
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score26 / 100 Market cap– P/E– Forward P/E-4,0 P/S– P/B– EV/EBITDA– Dividend yield– FCF yield– EPS-1,28 $ Net margin-50,8 % Return on equity-35,9 % Beta– Debt / equity0,42
52-week range 9,71 to 17,50
3-month average volume0,8 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen™ CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.

Employees
363
Country
United States
Fiscal year end
31. 12.
Data since
12. 6. 2024

Explore further

Similar companies SCTXALMRBLLNENGNWHWK

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account